TITLE

Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy

AUTHOR(S)
Tedaldi, Ellen M.; Baker, Rose K.; Moorman, Anne C.; Alzola, Carlos F.; Furhrer, Jack; McCabe, Robert E.; Wood, Kathleen C.; Holmberg, Scott D.
PUB. DATE
February 2003
SOURCE
Clinical Infectious Diseases;2/1/2003, Vol. 36 Issue 3, p363
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To ascertain the impact of hepatitis C virus (HCV) infection on human immunodeficiency virus (HIV) disease progression and associated death in the era of highly active antiretroviral therapy (HAART), we examined mortality rates, the presence of other diseases, and antiretroviral use in an observational cohort of 823 HIVinfected patients with and without HCV coinfection during the period of January 1996 through June 2001. Analyses were used to compare patient characteristics, comorbid conditions, and survival durations in HIVinfected and HIV-HCV-coinfected patients. HIV-HCV-coinfected persons did not have a statistically greater rate of acquired immunodeficiency syndrome or of renal or cardiovascular disease, but they did have more cases of cirrhosis and transaminase elevations. There were proportionately more deaths in the HIVHCV-coinfected group. Age, baseline CD4[sup +] cell count, and duration of HAART were significantly associated with survival, but HCV infection was not. HAART use was a strong predictor of increased duration of survival, suggesting that treatment is more important to survival than is HCV coinfection status.
ACCESSION #
9027416

 

Related Articles

  • Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Mohsen, A.H.; Easterbrook, P.J.; Taylor, C.; Portmann, B.; Kulasegaram, R.; Murad, S.; Wiselka, M.; Norris, S. // Gut;Jul2003, Vol. 52 Issue 7, p1035 

    Objectives: To compare the rate of hepatic fibrosis progression in hepatitis C virus (HCV) infected and human immunodeficiency virus (HIV)-HCV coinfected patients, and to identify factors that may influence fibrosis progression. Patients and methods: A total of 153 HCV infected and 55 HCV-HIV...

  • Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus. Martinez-Sierra, Carmen; Arizcorreta, Ana; Díaz, Fernando; Roldán, Rafael; Martín-Herrera, Leopoldo; Pérez-Guzmán, Eugenio; Girón-González, José A. // Clinical Infectious Diseases;2/15/2003, Vol. 36 Issue 4, p491 

    To evaluate the factors associated with the evolution of chronic hepatitis C in human immunodeficiency virus (HIV)-infected patients, a cross-sectional analysis of 41 HIV-infected patients with chronic hepatitis C (known as "HIV-HCV [hepatitis C virus]-coinfected patients") and a control group...

  • Deaths from hepatitis C overtake deaths from HIV in the US.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/3/2012, Vol. 344 Issue 7846, p12 

    The article reports that there are more individuals who died from hepatitis C (15, 106) in the U.S. in 2007 than those who died from HIV (12, 734) based on the analysis of U.S. death certificates.

  • Evolution of Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus in Patients Treated with Highly Active Antiretroviral Therapy. Torre, D.; Tambini, R.; Cadario, F.; Barbarini, G.; Moroni, M.; Basilico, C. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1579 

    Focuses on a study which examined patients coinfected with HIV and hepatitis C virus (HCV) who were treated with highly active antiretroviral therapy in Italy. Characteristics of the study population; Survival rate of patients coinfected with HIV and HCV; Evolution of HCV genotypes and disease.

  • Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS. Tedaldi, Ellen M.; Hullsiek, Katherine Hoppler; Malvestutto, Carlos D.; Arduino, Roberto C.; Fisher, Evelyn J.; Gaglio, Paul J.; Jenny-Avital, Elizabeth R.; McGowan, Joseph P.; Perez, George // Clinical Infectious Diseases;5/15/2003, Vol. 36 Issue 10, p1313 

    The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline...

  • Canada's Prisons: High Risk.  // Guide;Jun2003, Vol. 23 Issue 6, p112 

    Reports on an increase in HIV and hepatitis C infection rates in federal prisons in Canada. Voluntary tests for inmates; Likely causes of the infections.

  • HIV/HCV Koenfeksiyonu: Olgu Sunumu. KUMBASAR KARAOSMANOĞLU, Hayat; ALTUNTAŞ AYDIN, Özlem; RAHŞAN İNCE, Emine; NAZLICAN, Özcan // Viral Hepatitis Journal / Viral Hepatit Dergisi;Aug2013, Vol. 19 Issue 2, p89 

    HIV/HCV coinfection is common due to shared routes of transmission. Co-infection affects disease progression related to both agents and complicates treatment. In this report, a 48-year old male patient with HIV/HCV coinfection has been presented.

  • Table of Contents.  // Clinical Infectious Diseases;Dec2014, Vol. 59 Issue 12, pNP 

    A table of the contents for December 15, 2014 issue is presented.

  • Transmission of HCV NS5A Inhibitor–Resistant Variants Among HIV-Infected Men Who Have Sex With Men. Abravanel, Florence; Métivier, Sophie; Chauveau, Marie; Péron, Jean-Marie; Izopet, Jacques // Clinical Infectious Diseases;11/1/2016, Vol. 63 Issue 9, p1271 

    A letter to the editor is presented in response to the article about hepatitis C virus drug resistance associated HIV infection in men in the previous issue.

  • CROI 2013: The beat goes on -- progress in HIV, HCV infections. Volberding, Paul A. // Infectious Disease News;Apr2013, Vol. 26 Issue 4, p5 

    The author reflects on the advances in the prevention and treatment of HIV and hepatitis C virus (HCV) infections which were discussed at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Georgia.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics